ZYME peer analysis
Zymeworks (ZYME) against its competitors: price, today's move, 1-year return and market value side by side.
ZYME and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADCT ADC Therapeutics | $1.53 | 2.68% | -66.95% | $195.33M |
| ALXO ALX Oncology | $1.22 | 0.00% | -21.29% | – |
| CBIO Crescent Biopharma | $13.48 | -4.19% | 7.75% | $500.74M |
| CGEN Compugen | $1.98 | -2.94% | 20.00% | $187.56M |
| CLDX Celldex Therapeutics | $29.03 | -3.55% | 11.65% | $2.36B |
| CTMX CytomX Therapeutics | $2.34 | 2.18% | -29.73% | $509.88M |
| IMNM Immunome | $19.81 | 8.79% | 23.97% | – |
| MGNX MacroGenics | $2.40 | 0.84% | 50.47% | $152.88M |
| NRIX Nurix Therapeutics | $25.70 | -4.09% | 101.13% | – |
| XNCR Xencor | $29.68 | -0.47% | 110.05% | $2.22B |
| ZYME Zymeworks | $29.00 | 1.38% | 51.70% | $2.02B |
- ZYME's peers: ADCT (ADC Therapeutics), ALXO (ALX Oncology), CBIO (Crescent Biopharma), CGEN (Compugen), CLDX (Celldex Therapeutics), CTMX (CytomX Therapeutics), IMNM (Immunome), MGNX (MacroGenics).
Updated 2026-11-03 01:06 UTC